Plain-English translation of NCT07063888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of radiation therapy and chemotherapy given after surgery for intrahepatic cholangiocarcinoma, a cancer of the bile ducts inside the liver. The chemotherapy medication used is capecitabine, which helps destroy any remaining cancer cells. The goal is to reduce the chance that cancer will return and improve how long patients survive.
After surgery for this type of cancer, there is still a risk that cancer cells may have been left behind or may spread later. This trial is investigating whether giving radiation and chemotherapy together after surgery can lower that risk and help patients live longer without their cancer returning.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy sessions over several weeks, with chemotherapy given at the same time. After radiation ends, you will continue taking the chemotherapy medication by mouth for several more months. During the trial, doctors will monitor you closely with scans and blood tests to check how well the treatment is working and track any side effects. The study will follow you for at least 2 years to see whether your cancer returns and how long you survive.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China